|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Churg-Stauss syndrome with severe granulomatous angiitis and crescentic glomerulonephritis,which developed during therapy with a leukotriene receptor antagonist显示文摘 | Kanda T Tanio H Wu C | 2010 | Clin E~p Nephrol2010，14，6： | 1 |
| 2 | Severe respiratory muscle weakness related to long-term colchicine therapy 显示文摘 | Tanios MA El Gamal H Epstein SK | 2004 | RespirCare2004，49，2： | 1 |
| 3 | Structure activity re lationships of 32methyl and 3,32dimethyl analogs of 22(2,42di2 fluorophenyl)232(omega2substituted alkyl) sulfonyl 212(1H21,2,42triazol212yl)222propanols显示文摘 | Miyauchi H Kozuki K Tanio T | 1996 | Chem Pharm Bull1996，44，4： | 1 |
| 4 | Synthesis and anti fungal activity of alkylthio and alkylsulfonyl derivatives of SM2 8668显示文摘 | Miyauchi H Kozuki K Tanio T | 1996 | Bioorg Med Chem1996，4，2： | 1 |
| 5 | Structure-activity relationships of 3-methyl and 3,3-dimethyl analogs of 2-(2,4-difluorophenyl)-3-( omega-substituted alkyl) sulfonyl - 1-( 1H- 1,2,4-triazol-1-yl)-2-propanols显示文摘 | Kozuki K Tanio T | 1996 | Chem Pharm Bull1996，44，4： | 1 |
| 6 | Is ST segment re-elevation associated with reperfusion an indicator of marked myocardial damage after thromobolysis?显示文摘 | Kondo M Tamura K Tanio H | 1993 | J Am Coll Cardiol1993，21，1： | 1 |
| 7 | Churg-Strauss syndrome withsevere granulomatous angiitis and crescentic glomerulonephri-tis, which developed during therapy with a leukotriene receptorantagonist 显示文摘 | Kanda T Tanio H Wu C | 2010 | Clin Exp Nephrol2010，14，6： | 1 |
| 8 | Synthesis and antifungal activity of alkylthio and alkylsulfonyl derivatives of SM8668显示文摘 | Kozuki K Tanio T | 1996 | Bioorg Med Chem1996，4，2： | 1 |
| 9 | Churg-Strauss syndromewith severe granulomatous angiitis and crescentic glome-rulonephritis,which developed during therapy with a leuko-triene receptor antagonist显示文摘 | Kanda T Tanio H Wu C | 2010 | Clin Exp Nephrol2010，14，6： | 1 |
| 10 | Churg-Strauss syndrome with se- vere granulomatous angiitis and crescentic glomerulonephritis, which developed during therapy with a leukotriene receptor antag- onist 显示文摘 | KANDA T TANIO H WU C | 2010 | Clin Exp Nephrol2010，14，6： | 1 |
| 11 | Can we still miss tetrachloroethylene-induced lung disease? The emperor returns in new clothes显示文摘 | Tanios MA EI Gamal H Rosenberg J | 2004 | Respiration2004，71，6： | 1 |
| 12 | H, C and 5N backbone resonance assignments of the monomeric human M- ficolin fibrinogen-like domain secreted by Brevibaeillus choshinensis 显示文摘 | TANIO M KUSUNOKI H KOHNO T | 2014 | Biomolecular NMR Assignments2014，8，1： | 1 |
| 13 | Genomic diversity of colorectal cancer: Changing landscape and emerging targets显示文摘Improvements in screening and preventive measures have led to an increased detection of early stage colorectal cancers(CRC) where patients undergo treatment with a curative intent. Despite these efforts, a high proportion of patients are diagnosed with advanced stage disease that is associated with poor outcomes, as CRC remains one of the leading causes of cancer-related deaths in the world. The development of next generation sequencing and collaborative multiinstitutional efforts to characterize the cancer genome has afforded us with a comprehensive assessment of the genomic makeup present in CRC. This knowledge has translated into understanding the prognostic role of various tumor somatic variants in this disease. Additionally, the awareness of the genomic alterations present in CRC has resulted in an improvement in patient outcomes, largely due to better selection of personalized therapies based on an individual's tumor genomic makeup. The benefit of various treatments is often limited, where recent studies assessing the genomic diversity in CRC have identified the development of secondary tumor somatic variants that likely contribute to acquired treatment resistance. These studies have begun to alter the landscape of treatment for CRC that include investigating novel targeted therapies, assessing the role of immunotherapy and prospective, dynamic assessment of changes in tumor genomic alterations that occur during the treatment of CRC. | Daniel H Ahn Kristen K Ciombor Sameh Mikhail Tanios Bekaii-Saab | 2016 | World Journal of Gastroenterology2016，22，25： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员